PLAT and myeloid sarcoma: For example, a range of disease modifying treatments (DMTs) have been approved for primary progressive and relapsing forms of multiple sclerosis (MS), while reperfusion therapies such as intravenous thrombolysis (iv-tPA) and mechanical thrombectomy (MT) for acute ischemic stroke (AIS) substantially reduce a patient's risk of death and dependency (1, 2).